{
    "topic": "coronavirus",
    "source": "Yahoo! The 360",
    "bias": 1,
    "url": "https://news.yahoo.com/is-too-much-hope-being-put-into-a-coronavirus-vaccine-192703455.html",
    "title": "Is too much hope being put into a coronavirus vaccine?",
    "date": "2020-07-13",
    "authors": "Mike Bebernes",
    "content": "\u201c The 360 \u201d shows you diverse perspectives on the day \u2019 s top stories and debates .\nIt \u2019 s a commonly accepted truth that the only way the coronavirus pandemic will come to an end is through the development of an effective vaccine . The effort to accomplish that goal has been underway for months in countries around the world , at a scale and speed that have never been seen before .\nThere are currently more than 100 potential vaccines in some stage of development , some of which have advanced to human trials . The Trump administration launched \u201c Operation Warp Speed \u201d in May with the goal of having millions of doses available by the end of the year . Dr. Anthony Fauci , the nation \u2019 s top infectious disease expert , recently said he was \u201c cautiously optimistic \u201d a vaccine could be ready by early 2021 .\nExperts say the virus will continue to spread until about 70 percent of the population has developed immunity . A vaccine is the quickest and safest way to establish what \u2019 s known as \u201c herd immunity. \u201d The other path \u2014 waiting until enough people have been infected \u2014 could lead to millions of deaths , epidemiologists say .\nDespite promising progress on a number of vaccine candidates , there are still significant reasons to be skeptical of the idea that a game-changing vaccine is just a few months away , experts say . Developing a vaccine by the end of the year or even by next summer would shatter the record for the fastest vaccine ever developed , which currently stands at four years . Even if that extraordinary feat is accomplished , drug companies will still need to produce hundreds of millions of doses and distribute them to the people who need them .\nIt \u2019 s possible that will happen , but some experts worry about investing too much in what would be a best-case scenario . \u201c We \u2019 ve never seen everything go perfectly , \u201d a former Trump administration health official told Congress . A better plan , some argue , would be to prepare as if it might take years before a vaccine is widely available by developing effective systems of testing , tracing and therapeutic medicines that can last as long as they \u2019 re needed . There is even concern that the idea of a vaccine being right around the corner may be holding back efforts to put the virus mitigation measures we need right now in place .\nOthers have suggested that rushing development may backfire by increasing the risk that an unsafe vaccine might be the first to make it to market . Any setbacks could increase already pervasive anti-vaccine sentiment among the public , which may undermine herd immunity . There is also the possibility that any new vaccine may not be entirely effective or may provide immunity only for a short period of time .\n\u201c An approved coronavirus vaccine won \u2019 t do any good if people aren \u2019 t willing to roll up their sleeves for it. \u201d \u2014 Editorial , Pittsburgh Post-Gazette\nA vaccine won \u2019 t be a magic solution , but it \u2019 s still the best path out of the pandemic\n\u201c If you \u2019 re imagining there \u2019 ll be one golden day when a vaccine is approved and the pandemic will be over \u2014 Finally ! We can all crowd into one another \u2019 s living rooms and resume choir practice again \u2014 I \u2019 m afraid it won \u2019 t be quite like that . But it will be the beginning of the end . There \u2019 s much to be hopeful about , and enormous challenges lie ahead. \u201d \u2014 Caroline Chen , ProPublica\n\u201c It would be a shame if production and supply chain bottlenecks , such as the ones faced for medical supplies , slow down vaccine availability after discovery . Production must be done globally to prevent bottlenecks , hoarding and to facilitate efficient distribution of vaccines to local clinics. \u201d \u2014 Krishna B. Kumar , Mahshid Abir and Christopher Nelson , The Hill\nWaiting on a miracle cure in the future is causing unnecessary deaths right now\n\u201c Like an overly optimistic doctor , some policymakers are banking on a future vaccine that , at best , may arrive in 2021 while people are sick and dying now and the economy continues to be hobbled with an unclear path forward to stability . The tragedy is that there is a playbook that can reduce the number of cases and deaths right now. \u201d \u2014 Eric Schneider , Los Angeles Times",
    "content_original": "\u201cThe 360\u201d shows you diverse perspectives on the day\u2019s top stories and debates.\n\nWhat\u2019s happening\n\nIt\u2019s a commonly accepted truth that the only way the coronavirus pandemic will come to an end is through the development of an effective vaccine. The effort to accomplish that goal has been underway for months in countries around the world, at a scale and speed that have never been seen before.\n\nThere are currently more than 100 potential vaccines in some stage of development, some of which have advanced to human trials. The Trump administration launched \u201cOperation Warp Speed\u201d in May with the goal of having millions of doses available by the end of the year. Dr. Anthony Fauci, the nation\u2019s top infectious disease expert, recently said he was \u201ccautiously optimistic\u201d a vaccine could be ready by early 2021.\n\nExperts say the virus will continue to spread until about 70 percent of the population has developed immunity. A vaccine is the quickest and safest way to establish what\u2019s known as \u201cherd immunity.\u201d The other path \u2014 waiting until enough people have been infected \u2014 could lead to millions of deaths, epidemiologists say.\n\nWhy there\u2019s debate\n\nDespite promising progress on a number of vaccine candidates, there are still significant reasons to be skeptical of the idea that a game-changing vaccine is just a few months away, experts say. Developing a vaccine by the end of the year or even by next summer would shatter the record for the fastest vaccine ever developed, which currently stands at four years. Even if that extraordinary feat is accomplished, drug companies will still need to produce hundreds of millions of doses and distribute them to the people who need them.\n\nIt\u2019s possible that will happen, but some experts worry about investing too much in what would be a best-case scenario. \u201cWe\u2019ve never seen everything go perfectly,\u201d a former Trump administration health official told Congress. A better plan, some argue, would be to prepare as if it might take years before a vaccine is widely available by developing effective systems of testing, tracing and therapeutic medicines that can last as long as they\u2019re needed. There is even concern that the idea of a vaccine being right around the corner may be holding back efforts to put the virus mitigation measures we need right now in place.\n\nOthers have suggested that rushing development may backfire by increasing the risk that an unsafe vaccine might be the first to make it to market. Any setbacks could increase already pervasive anti-vaccine sentiment among the public, which may undermine herd immunity. There is also the possibility that any new vaccine may not be entirely effective or may provide immunity only for a short period of time.\n\nPerspectives\n\nVaccine skepticism may make reaching herd immunity difficult\n\n\u201cAn approved coronavirus vaccine won\u2019t do any good if people aren\u2019t willing to roll up their sleeves for it.\u201d \u2014 Editorial, Pittsburgh Post-Gazette\n\nA vaccine won\u2019t be a magic solution, but it\u2019s still the best path out of the pandemic\n\n\u201cIf you\u2019re imagining there\u2019ll be one golden day when a vaccine is approved and the pandemic will be over \u2014 Finally! We can all crowd into one another\u2019s living rooms and resume choir practice again \u2014 I\u2019m afraid it won\u2019t be quite like that. But it will be the beginning of the end. There\u2019s much to be hopeful about, and enormous challenges lie ahead.\u201d \u2014 Caroline Chen, ProPublica\n\nThe supply chain for vaccine materials could break down\n\n\u201cIt would be a shame if production and supply chain bottlenecks, such as the ones faced for medical supplies, slow down vaccine availability after discovery. Production must be done globally to prevent bottlenecks, hoarding and to facilitate efficient distribution of vaccines to local clinics.\u201d \u2014 Krishna B. Kumar, Mahshid Abir and Christopher Nelson, The Hill\n\nWaiting on a miracle cure in the future is causing unnecessary deaths right now\n\n\u201cLike an overly optimistic doctor, some policymakers are banking on a future vaccine that, at best, may arrive in 2021 while people are sick and dying now and the economy continues to be hobbled with an unclear path forward to stability. The tragedy is that there is a playbook that can reduce the number of cases and deaths right now.\u201d \u2014 Eric Schneider, Los Angeles Times",
    "source_url": "www.news.yahoo.com",
    "bias_text": "center",
    "ID": "hmJdUQgByeR3UtB5"
}